Incidence of left atrial abnormalities under treatment with dabigatran, rivaroxaban, and vitamin K antagonists

BACKGROUND: Non-vitamin K antagonist oral anticoagulants (NOACs) such as dabigatran or rivaroxaban are alternatives to vitamin K antagonists (VKAs) for prevention of stroke and systemic embolism in patients with atrial fibrillation (AF) and atrial flutter (AFL). Incidences of risk factors for left a...

Descripción completa

Detalles Bibliográficos
Autores principales: Reers, Stefan, Agdirlioglu, Tolga, Kellner, Michael, Borowski, Matthias, Thiele, Holger, Waltenberger, Johannes, Reppel, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073429/
https://www.ncbi.nlm.nih.gov/pubmed/27769294
http://dx.doi.org/10.1186/s40001-016-0235-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073429/
https://www.ncbi.nlm.nih.gov/pubmed/27769294
http://dx.doi.org/10.1186/s40001-016-0235-8

Ejemplares similares